Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Prospective Registry for Patients at High-Risk for Pancreatic Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 5,000
- Run by
- Mayo Clinic
See details and how to joinNCT06151223 - No phaseTaking peopleCollecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- Where
- Jacksonville, Phoenix, Rochester
- Age
- 18 years and over
- People
- 20,000
- Run by
- Mayo Clinic
See details and how to joinNCT00830557 - No phaseTaking peopleGastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
- Where
- Nashville
- Age
- 18 years and over
- People
- 5,000
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT00899626 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Houston, Milwaukee, Pittsburgh
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 2Taking peoplePurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
- Where
- Milwaukee, Scottsdale
- Age
- 18 years and over
- People
- 84
- Run by
- Medical College of Wisconsin
See details and how to joinNCT04683315 - Phase 1Taking peopleStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Where
- Aurora, Boston, Dallas, Huntersville, Layfayette, Madison, Nashville, New Brunswick, New York, Orange
- Age
- 18 years and over
- People
- 330 worldwide
- Run by
- I-Mab Biopharma US Limited
See details and how to joinNCT04900818 - No phaseTaking peopleDiagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
- Where
- Baltimore
- Age
- 18 years and over
- People
- 5,000
- Run by
- Johns Hopkins University
See details and how to joinNCT04473794 - Phase 2Taking peopleEvaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 72
- Run by
- Massachusetts General Hospital
See details and how to joinNCT04485286 - Phase 1/2Taking peopleA Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
- Where
- El Segundo, Maumee, New York, Summit
- Age
- 18 years and over
- People
- 144
- Run by
- Engeneic Pty Limited
See details and how to joinNCT07049055 - No phaseTaking peopleResistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
- Where
- Boston
- Age
- 18 years and over
- People
- 45
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05356117 - No phaseTaking peopleA Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 60
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07124611 - No phaseEnrolling by invitationEndoscopic Ultrasound Radiofrequency Ablation, Database Repository
- Where
- Indianapolis
- Age
- 14 years and over
- People
- 100
- Run by
- Indiana University
See details and how to joinNCT04693754 - Phase 1/2Taking peopleStudy of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Where
- Cleveland, Dallas, Denver, Fairfax, Grand Rapids, Huntersville, Maumee, Omaha, Orlando, Philadelphia, San Antonio, St Louis, West Valley City
- Age
- 18 years and over
- People
- 150
- Run by
- Tasca Therapeutics
See details and how to joinNCT07030257 - Phase 2Taking peopleA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Where
- Albany, Albuquerque, Amarillo, Anchorage, Ann Arbor, Atlanta, Augusta, Aurora, Austin, Baltimore, Bar Harbor, Birmingham, Bismarck, Boise, Boston, Bozeman, Buffalo, Burlington, Cedar City, Champaign, Charleston, Charlotte, Cheyenne, Chicago, Chippewa Falls, Cincinnati, Cleveland, Colby, Columbus, Concord, Dallas, Denver, Des Moines, Detroit, Durango, Eugene, Evansville, Fargo, Flagstaff, Fort Stockton, Fort Wayne, Fresno, Grand Junction, Green Bay, Honolulu, Hot Springs, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Knoxville, Lake Charles, Las Vegas, Lewiston, Lexington, Los Angeles, Madison, Memphis, Miami, Midland, Miles City, Milwaukee, Minneapolis, Mobile, Montgomery, Morgantown, Nashville, New Haven, New Orleans, New York, Norfolk, North Platte, Oklahoma City, Omaha, Orlando, Philadelphia, Phoenix, Pittsburgh, Portland, Quincy, Raleigh, Rapid City, Reno, Richmond, Roanoke, Rochester, Roswell, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Shreveport, Sioux Falls, Spokane, Springfield, St Louis, Syracuse, Tallahassee, Tampa, Tucson, Washington D.C., Wellsboro, Wichita, Wilmington
- Age
- 18 years and over
- People
- 40
- Run by
- Sameek Roychowdhury
See details and how to joinNCT06906562 - Phase 1/2Taking peoplePhase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- Where
- East Brunswick, Fairfax, Grand Rapids, Irving, San Antonio, San Francisco, West Valley City
- Age
- 18 years and over
- People
- 150
- Run by
- MBrace Therapeutics
See details and how to joinNCT07145255 - Phase 1Taking peopleA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Where
- Baltimore, Chicago, Dallas, Durham, Hackensack, Houston, Lexington, Los Angeles, Miami, Nashville, New York, Philadelphia, Sacramento, San Francisco, Scottsdale, Seattle, Tucson
- Age
- 18 years and over
- People
- 90
- Run by
- Clasp Therapeutics, Inc.
See details and how to joinNCT06778863 - No phaseTaking peoplePancreas Registry and High Risk Registry
- Where
- New York
- Age
- 18 years and over
- People
- 1,368
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT02775461 - No phaseTaking peopleInterrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 181
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT02393703 - Phase 1Taking peopleBinary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
- Where
- Houston
- Age
- 18 years and over
- People
- 45
- Run by
- Baylor College of Medicine
See details and how to joinNCT03740256 - No phaseTaking peoplePreliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 200
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT02478892 - Phase 1Not yet taking people in United StatesStudy of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 25
- Run by
- Aram Hezel
See details and how to joinNCT06203821 - Phase 1Not yet taking people in United StatesStudy Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
- Where
- Rochester
- Age
- 18 years and over
- People
- 24
- Run by
- Haoming (Carl) Qiu
See details and how to joinNCT06217666 - Phase 2Taking peopleRectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 78
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT06411795 - No phaseTaking peopleBlood Markers of Early Pancreas Cancer
- Where
- Omaha
- Age
- 19 years and over
- People
- 1,250
- Run by
- University of Nebraska
See details and how to joinNCT03568630 - Phase 3Taking peopleThe Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Where
- Boston, Miami Lakes, Ventura
- Age
- 18 years and over
- People
- 480
- Run by
- Quercis Pharma AG
See details and how to joinNCT06861088